GE HealthCare announces CareIntellect for Oncology

GE HealthCare announced CareIntellect for Oncology, a new cloud-first application that brings together multi-modal patient data from disparate systems into a single view, using generative AI to summarize clinical notes and reports. The application also surfaces relevant data allowing care teams to quickly understand disease progression and flag potential deviations from the treatment plan to help the clinician determine potential next steps and inform proactive interventions.

The application, which is planned to be available to customers in U.S. next year, will initially focus on prostate and breast cancer. It organizes structured and unstructured data (e.g., medical images, medical records, notes, and device readings), summarizes complex medical histories, supports treatment response assessments, helps assess clinical trial eligibility, and tracks adherence to treatment protocols in an easy-to-navigate view. This is the first application within GE HealthCare’s new CareIntellect offering of clinical and operational applications designed to help healthcare providers quickly and easily install new applications without having to take a costly and time-consuming product-by-product integration approach.

CareIntellect for Oncology quickly organizes multi-modal patient data from disparate systems to provide care teams with a concise view of the patient’s progressive treatment journey, while allowing clinicians to maintain full access to the source reports. The application will allow care teams to reduce or eliminate the time-consuming task of searching multiple databases—reducing a process that can take several hours, down to several minutes by eliminating the need to track down and synthesize information across multiple reports. The application is also able to flag risk of deviation from the treatment plan, helping the clinician determine potential next steps to intervene—for example, surfacing a patient’s missed lab work that could delay the next round of treatment. Additionally, CareIntellect for Oncology helps care teams assess potentially suitable clinical trials by comparing the patient’s health record to trial criteria.

Tampa General Hospital and UT Southwestern Medical Center will be early evaluators of CareIntellect for Oncology, and integration is already underway. The application is planned to be available widely to U.S. customers in 2025, with additional future expansion intended for Canada, the UK, and Ireland.

CareIntellect for Oncology is the first application available as part of GE HealthCare’s new CareIntellect family of clinical and operational applications. CareIntellect applications will use a common, cloud-first digital infrastructure that enables healthcare providers to quickly and easily onboard new applications and capabilities to help solve both clinical and operational needs. CareIntellect aims to help customers go through the integration process once, while allowing them to activate additional applications easily and securely to minimize costly and time-consuming additional product-by-product integration. It will also be compatible with providers’ existing single sign-on systems to avoid the hassle of multiple log-ins. This means hospitals could accelerate their digital transformation by spending less time with their IT setup and more time unlocking their data to drive operational efficiency improvements and more personalized care.